Arlene S Swern Selected Research

Cytokines

10/2012

Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arlene S Swern Research Topics

Disease

8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 10/2012
3	Multiple Myeloma 01/2021 - 08/2012
3	Neoplasms (Cancer) 12/2018 - 10/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018 - 10/2013
2	Anemia 01/2017 - 01/2015
1	Pain (Aches) 12/2018
1	Lymphocytosis 10/2018
1	Exanthema (Rash) 01/2015
1	Leukemia 10/2013
1	Fatigue 10/2013
1	Thrombocytopenia (Thrombopenia) 10/2012
1	Asthma (Bronchial Asthma) 12/2008
1	Type 2 Diabetes Mellitus (MODY) 10/2008
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2005

Drug/Important Bio-Agent (IBA)

5	Lenalidomide (CC 5013)FDA Link 01/2018 - 08/2012
4	Azacitidine (5 Azacytidine)FDA Link 01/2018 - 07/2013
2	montelukast (Singulair)FDA Link 12/2008 - 01/2005
1	idecabtagene vicleucelIBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	HematinicsIBA 01/2018
1	Bendamustine Hydrochloride FDA Link 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Epoetin Alfa (Epogen)FDA Link 10/2012
1	Erythropoietin FDA Link 10/2012
1	CytokinesIBA 10/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2012
1	Sitagliptin Phosphate (Januvia)FDA Link 10/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2008

Therapy/Procedure

6	Therapeutics 12/2018 - 10/2013
2	Duration of Therapy 10/2018 - 01/2015
1	Stem Cell Transplantation 12/2018
1	Transplantation 12/2018
1	Aftercare (After-Treatment) 01/2015